Table 2. Prevalence of antibodies to HSV–1 and HSV–2 at enrollment, WIHS 1994–95 cohort, by race and IFNL4 genotype (N = 1,431).

		African Americans
IFNL4-ΔG/TT Genotype	Total	HSV–1 Positive	p-value	HSV–2 Positive	p-value	HSV–1 or HSV–2 Positive	p-value
		N (%)		N (%)
Overall	1108	857 (77.3)		930 (83.9)	-	1079 (97.4)
TT/TT	168	124 (73.8)		137 (81.5)		163 (97.0)
ΔG/TT	505	393 (77.8)		418 (82.8)		488 (96.6)
ΔG/ΔG	435	340 (78.2)		375 (86.2)		428 (98.4)
ΔG/ΔG+ΔG/TT	940	733 (78.0)	0.23	793 (84.4)	0.36	916 (97.4)	0.75
		European Americans
IFNL4-ΔG/TT Genotype	Total	HSV–1 Positive	p-value	HSV–2 Positive	p-value	HSV–1 or HSV–2 Positive	p-value
		N (%)		N (%)		N (%)
Overall	323	185 (57.3)		201 (62.2)	-	273 (84.5)
TT/TT	134	73 (54.5)		90 (67.2)		116 (86.6)
ΔG/TT	151	87 (57.6)		86 (57.0)		121 (80.1)
ΔG/ΔG	38	25 (65.8)		25 (65.8)		36 (94.7)
ΔG/ΔG+ΔG/TT	189	112 (59.3)	0.39	111 (58.7)	0.12	157 (83.1)	0.39